Browsing Obstetrics & Gynaecology by Subject "Cancer"
Now showing items 1-3 of 3
-
Evaluating The Cost-Effectiveness of Repeated Serological Biomarker Screening Compared to the Khorana Risk Score for Guiding Thromboprophylaxis Prescription in Patients Receiving Chemotherapy
(2025)Background: The Khorana Risk Score (KRS), measured prior to treatment initiation, is the internationally recommended standard for guiding thromboprophylaxis prescriptions based on venous thromboembolism (VTE) risk in ... -
Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens
(Elsevier, 2010)Recent data has shown that hormone therapy (HT) increases the risk of cardiovascular and thromboembolic disease, particularly in users of oral HT. Phytoestrogens are popular alternatives to oestrogen therapy; however, their ... -
Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening.
(2013)Platinum resistance is a major cause of treatment failure in ovarian cancer. We previously identified matrix metalloproteinase 9 (MMP-9) as a potential therapeutic target of chemoresistant disease. A2780cis (cisplatin-resistant) ...
